Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 113, Issue 8, Pages 1186-1196
Publisher
Springer Nature
Online
2015-10-09
DOI
10.1038/bjc.2015.273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation
- (2015) Yassamine Lazrek et al. NEOPLASIA
- Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma
- (2014) Hao Ding et al. TUMOR BIOLOGY
- MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer
- (2014) Jun Pei et al. TUMOR BIOLOGY
- Inhibition of FoxO1 nuclear exclusion prevents metastasis of Glioblastoma
- (2014) Jin Chen et al. TUMOR BIOLOGY
- A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion
- (2013) Jiyeon Yoon et al. BMC GASTROENTEROLOGY
- The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway
- (2013) Jinju Park et al. Gastric Cancer
- Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer
- (2013) H-P Kim et al. ONCOGENE
- Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer
- (2012) H. Takamaru et al. Cancer Prevention Research
- Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction Cancer
- (2012) Yung-Jue Bang JOURNAL OF CLINICAL GASTROENTEROLOGY
- Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
- (2012) Fariz Nurwidya et al. Cancer Research and Treatment
- In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype
- (2011) Birgit Hotz et al. Gastric Cancer
- HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
- (2011) Wei Bao et al. GASTROENTEROLOGY
- Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
- (2011) Min A Kim et al. HISTOPATHOLOGY
- Cdc25A Regulates Matrix Metalloprotease 1 through Foxo1 and Mediates Metastasis of Breast Cancer Cells
- (2011) X. Feng et al. MOLECULAR AND CELLULAR BIOLOGY
- Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer
- (2011) H.-J. Nam et al. MOLECULAR CANCER THERAPEUTICS
- HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
- (2010) Wei Bao et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
- (2010) S Y Nam et al. BRITISH JOURNAL OF CANCER
- Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells
- (2010) Jay Shankar et al. CANCER RESEARCH
- FOXO1A Is a Target for HER2-Overexpressing Breast Tumors
- (2010) Y. Wu et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started